USANA HEALTH SCIENCES, INC. Net Income (Loss) Available to Common Stockholders, Basic
USANA HEALTH SCIENCES, INC. (USNA) reported Net Income (Loss) Available to Common Stockholders, Basic of $10.61 million for the 3-month period ending 2024-09-28, per its 10-Q filed 2024-11-05.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2024-11-05
- USANA HEALTH SCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2024-09-28 was $10.61M, a 6.52% decline year-over-year.
- USANA HEALTH SCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2024-06-29 was $10.43M, a 39.67% decline year-over-year.
- USANA HEALTH SCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2024-03-30 was $16.54M, a 10.04% decline year-over-year.
- USANA HEALTH SCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2023-12-30 was $16.77M, a 31.04% increase year-over-year.
- USANA HEALTH SCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was $63.79M, a 8.02% decline from fiscal 2022.
- USANA HEALTH SCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was $69.35M, a 40.47% decline from fiscal 2022.
- USANA HEALTH SCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was $116.50M, a 6.54% decline from fiscal 2021.
- USANA HEALTH SCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2021 was $124.66M, a 24.01% increase from fiscal 2019.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2024-09-28 | $10.61M 10-Q · filed 2024-11-05 | $21.04M derived: sum of 2 quarters · filed 2024-11-05 | $37.58M 10-Q · filed 2024-11-05 | $54.34M derived: sum of 4 quarters · filed 2024-11-05 |
| 2024-06-29 | $10.43M 10-Q · filed 2024-08-06 | $26.97M 10-Q · filed 2024-08-06 | $43.73M derived: sum of 3 quarters · filed 2024-08-06 | $55.08M derived: sum of 4 quarters · filed 2024-11-05 |
| 2024-03-30 | $16.54M 10-Q · filed 2024-05-07 | $33.30M derived: sum of 2 quarters · filed 2024-05-07 | $44.65M derived: sum of 3 quarters · filed 2024-11-05 | $61.94M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-12-30 | $16.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $28.11M derived: sum of 2 quarters · filed 2024-11-05 | $45.41M derived: sum of 3 quarters · filed 2024-11-05 | $63.79M 10-K · filed 2024-02-27 |
| 2023-09-30 | $11.35M 10-Q · filed 2024-11-05 | $28.64M derived: sum of 2 quarters · filed 2024-11-05 | $47.02M 10-Q · filed 2024-11-05 | $59.82M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-07-01 | $17.29M 10-Q · filed 2024-08-06 | $35.67M 10-Q · filed 2024-08-06 | $48.47M derived: sum of 3 quarters · filed 2024-08-06 | $63.40M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-04-01 | $18.38M 10-Q · filed 2024-05-07 | $31.18M derived: sum of 2 quarters · filed 2024-05-07 | $46.11M derived: sum of 3 quarters · filed 2024-05-07 | $65.26M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $12.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $27.72M derived: sum of 2 quarters · filed 2024-02-27 | $46.88M derived: sum of 3 quarters · filed 2024-02-27 | $69.35M 10-K · filed 2024-02-27 |
| 2022-10-01 | $14.93M 10-Q · filed 2023-11-07 | $34.09M derived: sum of 2 quarters · filed 2023-11-07 | $56.55M 10-Q · filed 2023-11-07 | $76.88M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | $19.16M 10-Q · filed 2023-08-08 | $41.63M 10-Q · filed 2023-08-08 | $61.95M derived: sum of 3 quarters · filed 2024-02-27 | $89.28M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | $22.47M 10-Q · filed 2023-05-09 | $42.79M derived: sum of 2 quarters · filed 2024-02-27 | $70.12M derived: sum of 3 quarters · filed 2024-02-27 | $108.35M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-01-01 | $20.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $47.65M derived: sum of 2 quarters · filed 2024-02-27 | $85.88M derived: sum of 3 quarters · filed 2024-02-27 | $116.50M 10-K · filed 2024-02-27 |
| 2021-10-02 | $27.33M 10-Q · filed 2022-11-08 | $65.56M derived: sum of 2 quarters · filed 2022-11-08 | $96.19M 10-Q · filed 2022-11-08 | $135.81M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-07-03 | $38.23M 10-Q · filed 2022-08-09 | $68.86M 10-Q · filed 2022-08-09 | $108.48M derived: sum of 3 quarters · filed 2023-02-28 | $138.99M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-04-03 | $30.62M 10-Q · filed 2022-05-11 | $70.25M derived: sum of 2 quarters · filed 2023-02-28 | $100.76M derived: sum of 3 quarters · filed 2023-02-28 | $128.73M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-01-02 | $39.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $70.14M derived: sum of 2 quarters · filed 2023-02-28 | $98.11M derived: sum of 3 quarters · filed 2023-02-28 | $124.66M 10-K · filed 2023-02-28 |
| 2020-09-26 | $30.51M 10-Q · filed 2021-11-10 | $58.48M derived: sum of 2 quarters · filed 2021-11-10 | $85.03M 10-Q · filed 2021-11-10 | $115.79M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-27 | $27.98M 10-Q · filed 2021-08-11 | $54.53M 10-Q · filed 2021-08-11 | $85.28M derived: sum of 3 quarters · filed 2022-03-01 | $109.50M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-28 | $26.55M 10-Q · filed 2021-05-11 | $57.31M derived: sum of 2 quarters · filed 2022-03-01 | $81.53M derived: sum of 3 quarters · filed 2022-03-01 | $102.91M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-28 | $30.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $54.98M derived: sum of 2 quarters · filed 2022-03-01 | $76.35M derived: sum of 3 quarters · filed 2022-03-01 | $100.53M 10-K · filed 2022-03-01 |
| 2019-09-28 | $24.22M 10-Q · filed 2020-11-03 | $45.60M derived: sum of 2 quarters · filed 2020-11-03 | $69.77M 10-Q · filed 2020-11-03 | $102.10M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-29 | $21.38M 10-Q · filed 2020-08-04 | $45.55M 10-Q · filed 2020-08-04 | $77.88M derived: sum of 3 quarters · filed 2021-03-02 | $108.92M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-30 | $24.17M 10-Q · filed 2020-05-05 | $56.50M derived: sum of 2 quarters · filed 2021-03-02 | $87.54M derived: sum of 3 quarters · filed 2021-03-02 | $121.45M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-29 | $32.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $63.37M derived: sum of 2 quarters · filed 2021-03-02 | $97.28M derived: sum of 3 quarters · filed 2021-03-02 | $126.22M 10-K · filed 2021-03-02 |
| 2018-09-29 | $31.04M 10-Q · filed 2019-11-05 | $64.95M derived: sum of 2 quarters · filed 2019-11-05 | $93.89M 10-Q · filed 2019-11-05 | $88.04M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $33.91M 10-Q · filed 2019-08-06 | $62.85M 10-Q · filed 2019-08-06 | $57.00M derived: sum of 3 quarters · filed 2020-02-25 | $80.77M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $28.95M 10-Q · filed 2019-05-07 | $23.09M derived: sum of 2 quarters · filed 2020-02-25 | $46.86M derived: sum of 3 quarters · filed 2020-02-25 | $70.12M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-30 | -$5.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $17.92M derived: sum of 2 quarters · filed 2020-02-25 | $41.18M derived: sum of 3 quarters · filed 2020-02-25 | $62.53M 10-K · filed 2020-02-25 |
| 2017-09-30 | $23.77M 10-Q · filed 2018-11-07 | $47.03M derived: sum of 2 quarters · filed 2018-11-07 | $68.39M 10-Q · filed 2018-11-07 | $90.27M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-07-01 | $23.26M 10-Q · filed 2018-08-08 | $44.62M 10-Q · filed 2018-08-08 | $66.50M derived: sum of 3 quarters · filed 2019-02-26 | $96.60M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-04-01 | $21.36M 10-Q · filed 2018-05-09 | $43.24M derived: sum of 2 quarters · filed 2019-02-26 | $73.34M derived: sum of 3 quarters · filed 2019-02-26 | $99.10M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $21.88M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $51.98M derived: sum of 2 quarters · filed 2019-02-26 | $77.74M derived: sum of 3 quarters · filed 2019-02-26 | $100.04M 10-K · filed 2019-02-26 |
| 2016-10-01 | $30.10M 10-Q · filed 2017-11-08 | $55.86M derived: sum of 2 quarters · filed 2017-11-08 | $78.16M 10-Q · filed 2017-11-08 | $102.13M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-07-02 | $25.76M 10-Q · filed 2017-08-09 | $48.06M 10-Q · filed 2017-08-09 | $72.03M derived: sum of 3 quarters · filed 2018-02-28 | $97.64M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-04-02 | $22.30M 10-Q · filed 2017-05-10 | $46.27M derived: sum of 2 quarters · filed 2018-02-28 | $71.88M derived: sum of 3 quarters · filed 2018-02-28 | $97.29M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-01-02 | $23.97M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $49.58M derived: sum of 2 quarters · filed 2018-02-28 | $74.99M derived: sum of 3 quarters · filed 2018-02-28 | $94.67M 10-K · filed 2018-02-28 |
| 2015-10-03 | $25.61M 10-Q · filed 2016-11-09 | $51.02M derived: sum of 2 quarters · filed 2016-11-09 | $70.70M 10-Q · filed 2016-11-09 | $92.00M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-07-04 | $25.42M 10-Q · filed 2016-08-09 | $45.10M 10-Q · filed 2016-08-09 | $66.40M derived: sum of 3 quarters · filed 2017-03-01 | $85.89M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-04-04 | $19.68M 10-Q · filed 2016-05-11 | $40.98M derived: sum of 2 quarters · filed 2017-03-01 | $60.48M derived: sum of 3 quarters · filed 2017-03-01 | $79.78M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-01-03 | $21.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $40.80M derived: sum of 2 quarters · filed 2017-03-01 | $60.10M derived: sum of 3 quarters · filed 2017-03-01 | $76.64M 10-K · filed 2017-03-01 |
| 2014-09-27 | $19.50M 10-Q · filed 2015-11-12 | $38.80M derived: sum of 2 quarters · filed 2015-11-12 | $55.34M 10-Q · filed 2015-11-12 | $75.62M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-06-28 | $19.30M 10-Q · filed 2015-08-12 | $35.84M 10-Q · filed 2015-08-12 | $56.12M derived: sum of 3 quarters · filed 2016-03-01 | $72.87M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-03-29 | $16.54M 10-Q · filed 2015-05-13 | $36.82M derived: sum of 2 quarters · filed 2016-03-01 | $53.57M derived: sum of 3 quarters · filed 2016-03-01 | $77.78M derived: sum of 4 quarters · filed 2016-03-01 |
| 2013-12-28 | $20.28M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $37.03M derived: sum of 2 quarters · filed 2016-03-01 | $61.24M derived: sum of 3 quarters · filed 2016-03-01 | $79.02M 10-K · filed 2016-03-01 |
| 2013-09-28 | $16.75M 10-Q · filed 2014-11-06 | $40.96M derived: sum of 2 quarters · filed 2014-11-06 | $58.74M 10-Q · filed 2014-11-06 | $77.19M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-06-29 | $24.21M 10-Q · filed 2014-08-05 | $41.99M 10-Q · filed 2014-08-05 | $60.44M derived: sum of 3 quarters · filed 2015-03-17 | $77.93M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-03-30 | $17.78M 10-Q · filed 2014-05-07 | $36.23M derived: sum of 2 quarters · filed 2015-03-17 | $53.72M derived: sum of 3 quarters · filed 2015-03-17 | $70.46M derived: sum of 4 quarters · filed 2015-03-17 |
| 2012-12-29 | $18.45M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | $35.94M derived: sum of 2 quarters · filed 2015-03-17 | $52.68M derived: sum of 3 quarters · filed 2015-03-17 | $66.43M 10-K · filed 2015-03-17 |
| 2012-09-29 | $17.49M 10-Q · filed 2013-11-07 | $34.23M derived: sum of 2 quarters · filed 2013-11-07 | $47.99M 10-Q · filed 2013-11-07 | $61.15M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | $16.75M 10-Q · filed 2013-08-08 | $30.50M 10-Q · filed 2013-08-08 | $43.66M derived: sum of 3 quarters · filed 2014-03-13 | $56.04M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $13.75M 10-Q · filed 2013-05-07 | $26.91M derived: sum of 2 quarters · filed 2014-03-13 | $39.30M derived: sum of 3 quarters · filed 2014-03-13 | $53.15M derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $13.16M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $25.55M derived: sum of 2 quarters · filed 2014-03-13 | $39.40M derived: sum of 3 quarters · filed 2014-03-13 | $50.75M 10-K · filed 2014-03-13 |
| 2011-10-01 | $12.38M 10-Q · filed 2012-11-07 | $26.24M derived: sum of 2 quarters · filed 2012-11-07 | $37.59M 10-Q · filed 2012-11-07 | |
| 2011-07-02 | $13.86M 10-Q · filed 2012-08-08 | $25.21M 10-Q · filed 2012-08-08 | ||
| 2011-01-01 | $45.65M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |